Table 1.

Baseline characteristics of patients readmitted within 30 days of index admission versus nonreadmitted patients. Values are mean or n (%) unless otherwise specified.

CharacteristicsEarly Readmission, n = 154Not Readmitted, n = 301p
Age, yrs52.651.20.4
Female138 (89.6)273 (90.7)0.7
Ethnicity
  White66 (42.9)157 (52.2)0.0001
  Hispanic28 (18.2)64 (21.3)0.33
  African American42 (27.3)56 (18.6)0.07
  Asian16 (10.4)18 (6.0)NS
  Unknown2 (1.3)5 (1.7)NS
Insurance
  Medicare*9 (5.8)15 (5.0)0.31
  Medicare + private32 (20.1)62 (20.6)0.9
  Medicaid**17 (11.0)21 (7.0)0.0075
  Medicare-Medicaid35 (22.7)51 (16.9)0.0008
  Private54 (35.7)142 (47)0.0004
  Uninsured7 (4.5)10 (303)0.71
Biochemical1
  Albumin, g/dl3.473.81< 0.0001
  Creatinine, mg/dl2.31.15< 0.0001
  Hemoglobin, g/dl10.111.2< 0.0001
  Immunosuppressive use102 (66.2)150 (50)0.001
  Steroid dose inpatient232.228.40.27
  Steroid dose outpatient39.56.90.24
  CCI4.793.31NS
  SDI2.751.58NS
  • * Government medical insurance for the elderly.

  • ** Government medical insurance.

  • 1 All laboratory values were included in average calculation and may include multiple values for the same patient.

  • 2 Steroid dose inpatient was calculated by summing the total mg of prednisone (or prednisone equivalent) during hospital course and dividing it by the length of stay.

  • 3 Steroid dose outpatient was the mg of prednisone (or prednisone equivalent) patient was taking at discharge. NS: not significant; CCI: Charlson Comorbidity Index; SDI: Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index.